Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
Holding LIXT?
Track your performance easily
LIXT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.31 - $4.42
Previous Close$1.89
Volume48.66K
Average Volume (3M)610.99K
Market Cap
$4.39M
Enterprise Value$1.79M
Total Cash (Recent Filing)$2.60M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Apr 27, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.83
Shares Outstanding2,249,290
10 Day Avg. Volume3,541,413
30 Day Avg. Volume610,987
Standard Deviation0.25
R-Squared0.00129
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-3.38
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lixte Biotechnology Holdings News
PremiumCompany Announcements
Lixte Biotechnology Appoints New Chief Medical Officer
Ownership Overview
5.95%
Insiders
0.67% Mutual Funds
3.18% Other Institutional Investors
89.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LIXT FAQ
What was Lixte Biotechnology Holdings’s price range in the past 12 months?
Lixte Biotechnology Holdings lowest stock price was $1.31 and its highest was $4.42 in the past 12 months.
What is Lixte Biotechnology Holdings’s market cap?
Currently, no data Available
When is Lixte Biotechnology Holdings’s upcoming earnings report date?
Lixte Biotechnology Holdings’s upcoming earnings report date is Apr 27, 2018 which is 2389 days ago.
How were Lixte Biotechnology Holdings’s earnings last quarter?
Currently, no data Available
Is Lixte Biotechnology Holdings overvalued?
According to Wall Street analysts Lixte Biotechnology Holdings’s price is currently Overvalued.
Does Lixte Biotechnology Holdings pay dividends?
Lixte Biotechnology Holdings does not currently pay dividends.
What is Lixte Biotechnology Holdings’s EPS estimate?
Lixte Biotechnology Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lixte Biotechnology Holdings have?
Lixte Biotechnology Holdings has 2,249,290 shares outstanding.
What happened to Lixte Biotechnology Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lixte Biotechnology Holdings?
Currently, no hedge funds are holding shares in LIXT
---
Lixte Biotechnology Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.00%
12-Months-Change
Fundamentals
Return on Equity
-163.33%
Trailing 12-Months
Asset Growth
-13.81%
Trailing 12-Months
Company Description
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings, Inc. engages in the development of drugs for cancer treatment. It uses biomarker technology to identify enzyme targets associated with serious common diseases and designs novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on August 9, 2005 and is headquartered in East Setauket, NY.
---
Technical Analysis
Advaxis
―
Cyclacel Pharmaceuticals
―
Cellectar Biosciences
―
SELLAS Life Sciences Group
―
---